TAM
ALXN
Taurus Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-116,873
| Closed | -$21.5M | – | 97 |
|
|
2021
Q2 | $21.5M | Sell |
116,873
-5,440
| -4% | -$999K | 2.24% | 17 |
|
|
2021
Q1 | $18.7M | Sell |
122,313
-2,920
| -2% | -$447K | 2.16% | 20 |
|
|
2020
Q4 | $19.6M | Sell |
125,233
-24,325
| -16% | -$3.8M | 2.34% | 17 |
|
|
2020
Q3 | $17.1M | Sell |
149,558
-210
| -0.1% | -$24K | 2.12% | 20 |
|
|
2020
Q2 | $16.8M | Sell |
149,768
-875
| -0.6% | -$98.2K | 2.33% | 17 |
|
|
2020
Q1 | $13.5M | Buy |
150,643
+17,975
| +14% | +$1.61M | 2.24% | 20 |
|
|
2019
Q4 | $14.3M | Sell |
132,668
-47,342
| -26% | -$5.12M | 1.87% | 23 |
|
|
2019
Q3 | $17.6M | Buy |
180,010
+30,625
| +21% | +$3M | 2.51% | 17 |
|
|
2019
Q2 | $19.6M | Buy |
149,385
+46,794
| +46% | +$6.13M | 2.67% | 15 |
|
|
2019
Q1 | $13.9M | Sell |
102,591
-30,200
| -23% | -$4.08M | 1.94% | 23 |
|
|
2018
Q4 | $12.9M | Buy |
132,791
+5,735
| +5% | +$558K | 2.07% | 18 |
|
|
2018
Q3 | $17.7M | Buy |
127,056
+20,500
| +19% | +$2.85M | 2.39% | 14 |
|
|
2018
Q2 | $13.2M | Buy |
106,556
+985
| +0.9% | +$122K | 1.93% | 20 |
|
|
2018
Q1 | $11.8M | Buy |
105,571
+1,615
| +2% | +$180K | 1.77% | 26 |
|
|
2017
Q4 | $12.4M | Buy |
103,956
+85,456
| +462% | +$10.2M | 1.83% | 26 |
|
|
2017
Q3 | $2.6M | Hold |
18,500
| – | – | 0.4% | 52 |
|
|
2017
Q2 | $2.25M | Buy |
+18,500
| New | +$2.25M | 0.35% | 54 |
|